A microchip inserted under the skin has been shown for the first time to successfully deliver a bone-loss drug to a small sample of women, according to US-led research published Thursday.
Related posts:
Depressed Teens Who Respond to Treatment Less Likely to Abuse Drugs
Michigan to Look at Contamination Levels in Lake St. Clair
Insight: Breast implant scandal shows regulators in dark on risk
Health Highlights: July 10, 2012
CDC: Young adults down 9 drinks when they binge
Controversial Down's syndrome testing gets Swiss go-ahead